Loading provider…
Loading provider…
Nuclear Medicine Physician in New York, NY
NPI: 1275552630Primary Employer
Memorial Nuclear Medicine Group
mskcc.org
HQ Phone
Get DO Mark's Phone Numberphone_androidMobile
Get DO Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License

NJ State License
2007 - 2027

NY State License
2002 - 2025

OH State License
2001 - 2002

American Board of Nuclear Medicine
Nuclear Medicine
Michigan State University College Of Osteopathic Medicine
osteopathicmedicine.msu.edu
Medical School
Until 2000
Memorial Sloan Kettering Cancer Center
Residency • Nuclear Medicine
2000 - 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 78815Nuclear medicine study with CT imaging skull base to mid-thigh | 615 | 623 |
| 2 | 78816Nuclear medicine study with CT imaging whole body | 71 | 73 |
| 3 | 79101Radioactive material therapy into vein | 60 | 88 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 28 | 32 |
| 5 | 99202New patient office or other outpatient visit, typically 20 minutes | 24 | 24 |
Non-invasive metabolic imaging of brain tumours in the era of precision medicine
Authors: Michelle M. Kim, Abhijit Parolia, Mark Dunphy, Sriram Venneti
Publication Date: 2016-12
Authors: Inda, Maria Carmen, Joshi, Suhasini, Wang, Tai, Bolaender, Alexander, Gandu, Srinivasa, Koren Iii, John, Che, Alicia Yue, Taldone, Tony, Yan, Pengrong, Sun, Weilin, Uddin, Mohammad, Panchal, Palak, Riolo, Matthew, Shah, Smit, Barlas, Afsar, Xu, Ke, Chan, Lon Yin L, Gruzinova, Alexandra, Kishinevsky, Sarah, Studer, Lorenz, Fossati, Valentina, Noggle, Scott A, White, Julie R, de Stanchina, Elisa, Sequeira, Sonia, Anthoney, Kyle H, Steele, John W, Manova-Todorova, Katia, Patil, Sujata, Dunphy, Mark P, Pillarsetty, NagaVaraKishore, Pereira, Ana C, Erdjument-Bromage, Hediye, Neubert, Thomas A, Rodina, Anna, Ginsberg, Stephen D, De Marco Garcia, Natalia, Luo, Wenjie, Chiosis, Gabriela
Journal: Nat Commun
Publication Date: 2020-01-16
Correction to: Optimizing 90Y Particle Density Improves Outcomes After Radioembolization.
Authors: Franz Boas, Majid Maybody
Journal: Cardiovasc Intervent Radiol
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DRUG: 89Zr-DFO-SC16.56, DRUG: SC16.56, Phase I, Cohort 2, DRUG: SC16.56, Phase I, Cohort 3, DRUG: SC16.56, Phase II
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DIAGNOSTIC_TEST: PET/MR with [18F]PARPi, DRUG: [18F]PARPi
Lead Sponsor: Samus Therapeutics, Inc.
Collaborators: Weill Medical College of Cornell University, Memorial Sloan Kettering Cancer Center, Rockefeller University
Intervention / Treatment: DEVICE: PET Scan, OTHER: Blood Draws, DRUG: PU-AD